About Zephyr AI
Zephyr AI is a company based in United States founded in 2020 by Jeffrey Sherman and Yisroel Brumer. Zephyr AI has raised $129.85 million across 2 funding rounds from investors including Verily, Lilly and MedStar Health. Zephyr AI offers products and services including Zephyr AI Platform, Predictive Modeling Tool, and Companion Diagnostics. Zephyr AI operates in a competitive market with competitors including Precisionlife, Chemify, Transaction Data Systems, RevolKa and OpenEye Scientific, among others.
- Headquarter United States
- Founders Jeffrey Sherman, Yisroel Brumer
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zephyr Ai, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$129.85 M (USD)
in 2 rounds
-
Latest Funding Round
$111.35 M (USD), Series A
Oct 27, 2023
-
Investors
Verily
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zephyr AI
Zephyr AI offers a comprehensive portfolio of products and services, including Zephyr AI Platform, Predictive Modeling Tool, and Companion Diagnostics.
Provides machine learning tools for drug development insights.
Generates forecasts for therapeutic risk stratification.
Offers AI-enabled support for clinical workflows.
People of Zephyr AI
Unlock access to complete
Funding Insights of Zephyr AI
Zephyr AI has successfully raised a total of $129.85M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $111.35 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zephyr AI
Zephyr AI has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Verily, Lilly and MedStar Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Revolution is recognized as a D.C.-based investment firm.
|
Locked | Locked | Locked | |
|
Diversified asset management services are offered by EPIQ.
|
Locked | Locked | Locked | |
|
AME Cloud Ventures is focused on investing in data-driven technology companies.
|
Locked | Locked | Locked |
Investor details for Zephyr AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zephyr AI
Investment portfolio details for Zephyr AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zephyr AI
Detailed financials for Zephyr AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zephyr Ai Comparisons
Peer comparison for Zephyr AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zephyr AI
Zephyr AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Precisionlife, Chemify, Transaction Data Systems, RevolKa and OpenEye Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-enabled platforms for drug discovery and precision medicine are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for pharmaceutical and materials research.
|
|
| Locked | Locked | Locked |
Software development services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
AI development services are provided for the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and design are enabled by a cloud-based platform.
|
Detailed competitors of Zephyr AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zephyr Ai
Complete news archive for Zephyr AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zephyr AI
Zephyr AI was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Zephyr AI is headquartered in United States.
Zephyr AI is a funded company, having raised a total of $129.85M across 2 funding rounds to date.
Zephyr AI offers Zephyr AI Platform, Predictive Modeling Tool, Companion Diagnostics while focusing on providing healthcare solutions, biopharma outsourcing, and software development services. Provider of AI development services for biopharma sector. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
Zephyr AI's top competitors include Chemify, RevolKa and Precisionlife.
Zephyr AI offers Zephyr AI Platform, Predictive Modeling Tool, and Companion Diagnostics.
Zephyr AI has 13 investors. Key investors include Verily, Lilly, MedStar Health, EPIQ, and Revolution.